Advancing peptide synthesis & purification

Scientists worldwide trust Gyros Protein Technologies for transformational peptide synthesis.

EXPLORE OUR SOLUTIONS

Elevate Your Peptide Synthesis with Advanced Automated Solutions

Manage a wide range of synthesis scales and workflows with configurations and functionalities that meet your research needs.

21: https://www.gyrosproteintechnologies.com/peptides/products/purepep-chorus-peptide-synthesizer

PurePep Chorus - Modular, scalable configuration

PurePep® Chorus

Modular, scalable configuration

21: https://www.gyrosproteintechnologies.com/peptides/products/symphony-x-peptide-synthesizer

Symphony X - Functionality of 24 synthesizers in one

Symphony® X

Functionality of 24 synthesizers in one

21: https://www.gyrosproteintechnologies.com/peptides/products/purepep-sonata-plus-peptide-synthesizer

PurePep Sonata+ - Mid-pilot scale

PurePep® SONATA®+

Mid-pilot scale
Complex Peptides - Tight Timelines png (1)

WEBINAR

One peptide, three orthogonal routes: Notes from a Semaglutide synthesis program.
June 24, 2026 

Learn more and register
PurePep EasyClean (PEC™) 2.0. Simplified peptide purification without the solubility headache. Now available in 96-well plate format for library purification. 

PurePep EasyClean (PEC™) 2.0.

Simplified peptide purification without the solubility headache. Now available in 96-well plate format for library purification. 

 Explore PEC 2.0

Manage a wide range of synthesis scales and workflows with configurations and functionality that meet your research needs

“We can produce more and get results quicker while maintaining our high quality standard.”

Fueling R&D breakthroughs

Our peptide synthesizers accelerate research in some of the most critical applications in the fields of science and medicine.

Solid-phase peptide synthesis (SPPS) involves the successive addition of protected amino acid derivatives to a growing peptide chain immobilized on a solid phase, including deprotection and washing steps to remove unreacted groups and also side products.

Solid Phase Peptide Synthesis

Peptide synthesis in therapeutic & vaccine research

Therapeutics & Vaccines
Oncology researchers use peptides in the form of patient-specific neoantigen vaccines as immunotherapy cancer treatments

Oncology Peptide Therapeutics

Peptide nucleic acids (PNAs) are a class of modified peptides with a repetitive polypeptide-like backbone of N-(2-aminoethyl) glycine to which nucleic acid bases are attached with spacing analogous to the distances in native nucleic acid structures.

PNAs
Peptoids belong to a class of molecules known as peptidomimetics, the molecules that mimic the biologic interactions of peptides

Peptoids
Synthetic foldamers are artificial molecules including peptides, nucleic acids, and polysaccharides, whose monomer sequence enables them to spontaneously fold into a defined three-dimensional conformation that is stable in biological environments

Foldamers
Oligonucleotides, or short synthetic chains of nucleic acids, are a growing class of therapeutics with FDA approved therapies primarily for genetic diseases, but with many clinical studies underway for use in treating cancers

Oligos
Peptide synthesis platforms from Protein Technologies enable a wide range of biomedical research across multiple applications and at any scale

General Research

Keeping you current

Stay abreast of the latest scientific developments impacting biopharmaceutical research.

Read PurePep

Synthesis Challenges in Complex Peptides and Personalized Therapies | PurePep Blog

Discover the challenges and solutions in complex peptide synthesis for personalized therapies, with insights from Oliver Reimann ahead of his upcoming PurePep® webinar.

3 Peptide Purification Bottlenecks Slowing Your Research | PurePep Blog

Discover how HPLC delays, precipitation issues, and high costs slow peptide purification—plus a precipitation-free solution that saves 3-4 days per cycle.

Getting Started with Automated Peptide Synthesis Guide | PurePep Blog

Master automated peptide synthesis with expert insights on technology, workflows, and optimization strategies for biotech innovation, whether automating manual processes or moving synthesis in-house.

In-house peptide synthesis reduces costs and shortens turnaround times | PurePep Blog

Discover how Ab Biotechnology cut timelines by 50% and achieved a 2-year ROI by adopting in-house peptide synthesis with Gyros Protein Technologies.

Find our where to meet the Peptide team from Gyros Protein Technologies

Upcoming Events

Find our where to meet our team.
Learn more
Resource Library - Discover in-depth research, documentation, and references to support your work.

Resource Library

Discover in-depth research, documentation, and references to support your work.
Learn more
Ordering Information, ge pricing information, and place your order

Ordering Information

Connect with your sales representative, get pricing information, and place your order.
Learn more